Current Edition


7th Annual Publication and Clinical Trial Transparency

Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge between the key stakeholders from …

Continue Reading →

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children with Debilitating, Lifelong Hereditary Disease Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), Kyowa …

Continue Reading →